Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease-Reference-Cited by-同舟云学术

Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease

Published:2021-11-01 Issue:11 Volume:78 Page:1270
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Blumenthal James A.¹,Smith Patrick J.¹,Jiang Wei¹,Hinderliter Alan²,Watkins Lana L.¹,Hoffman Benson M.¹,Kraus William E.³,Liao Lawrence³,Davidson Jonathan¹,Sherwood Andrew¹

Affiliation:

1. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina

2. Department of Medicine, University of North Carolina at Chapel Hill

3. Department of Medicine, Duke University Medical Center, Durham, North Carolina

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2783295/jamapsychiatry_blumenthal_2021_oi_210050_1635884821.48255.pdf

Reference58 articles.

1. Economic costs of anxiety disorders.;DuPont;Anxiety,1996

2. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.;Kessler;Arch Gen Psychiatry,2005

3. US Census Bureau–assessed prevalence of anxiety and depressive symptoms in 2019 and during the 2020 COVID-19 pandemic.;Twenge;Depress Anxiety,2020

4. Anxiety disorders and comorbid medical illness.;Roy-Byrne;Gen Hosp Psychiatry,2008

5. Anxiety as a risk factor in cardiovascular disease.;Allgulander;Curr Opin Psychiatry,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating depression and acute coronary syndrome care in low resource hospitals in China: the I-CARE randomised clinical trial;The Lancet Regional Health - Western Pacific;2024-07

2. Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting;BMJ Evidence-Based Medicine;2024-06-05

3. Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database;Journal of Psychopharmacology;2024-04-27

4. The effect of Qi‐Shao‐Tong‐Mai‐An‐Shen herbal paste on coronary heart disease patients with depression and/or anxiety: Study protocol for a randomized controlled trial;Advanced Chinese Medicine;2024-04

5. Correlation Between Blood Cadmium Levels and Platelet Characteristics, As Well As Their Impact on Susceptibility to Coronary Heart Disease: Findings from NHANES 2005–2018 Data;Cardiovascular Toxicology;2024-03-06